4.5 Article

FHUSPA2/10 is a bactericidal monoclonal antibody targeting multiple repeated sequences of Moraxella catarrhalis UspA2

Journal

VACCINE
Volume 40, Issue 45, Pages 6520-6527

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2022.09.048

Keywords

UspA2; Epitope mapping; Monoclonal antibody; HDX-MS; Electron microscopy

Ask authors/readers for more resources

Moraxella catarrhalis is an important respiratory pathogen associated with various respiratory diseases. Its surface protein A2 (UspA2) plays a role in the early stage of infection and contributes to bacterial serum resistance. The study provides insights into the structure and function of UspA2 and identifies key amino acids involved in its binding, highlighting its potential as a vaccine candidate against M. catarrhalis.
Moraxella catarrhalis is an important and common respiratory pathogen that can cause Otitis Media, Community Acquired Pneumonia, and has been associated with an increased risk of exacerbations in chronic obstructive pulmonary disease in adults, leading to morbidity and mortality. Its ubiquitous sur-face protein A2 (UspA2) has been shown to interact with host structures and extracellular matrix pro-teins, suggesting a role at an early stage of infection and a contribution to bacterial serum resistance. The UspA proteins are homo-trimeric autotransporters that appear as a lollipop-shaped structure in elec-tron micrographs. They are composed of an N-terminal head with adhesive properties, followed by a stalk, which ends by an amphipathic helix and a C-terminal membrane domain. The three family mem-bers UspA1, UspA2 and UspA2H, present different amino acid signatures both at the head and membrane -spanning regions. By combining electron microscopy, hydrogen deuterium exchange mass spectrometry and protein modeling, we identified a shared and repeated epitope recognized by FHUSPA2/10, a potent cross-bactericidal monoclonal antibody raised by UspA2 and deduced key amino acids involved in the binding. The finding strengthens the potential of UspA2 to be incorporated in a vaccine formulation against M. catarrhalis.(c) 2022 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available